Education
About Us
Working with TipRanks
Follow Us
Jason Campagna Insider Profile
4 Followers
Jason Campagna, CMO at Intercept Pharma, holds 37.50K shares in Q32 Bio (Ticker: QTTB), holds 7.93K shares in Intercept Pharma (Ticker: ICPT).
Jason Campagna Intercept Pharma (ICPT)CMO
Intercept Pharma (ICPT)
CMO
Not Ranked
Jason Campagna has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CMO
Roles that Jason Campagna holds in companies
Most Profitable Insider Trade
Stock:
Intercept Pharma
(ICPT)
(ICPT)
Rating:Informative Sell
Date:Aug 20, 2020 - Aug 20, 2021
Return:+73.30%
The most profitable trade made by Jason Campagna
Jason Campagna's Trading History
Intercept Pharma
Jan 05, 2021
―
Uninformative Sell
16.45K
$150.69K
Q32 Bio
Feb 26, 2025
CMO
Uninformative Buy
―
$70.50K
List of latest transactions for each holding click on a transaction to see Jason Campagna's performance on stock
You May Also Like
Jason Campagna insider profile FAQ
What is the percentage of profitable transactions made by Jason Campagna?
The percentage of profitable transactions made by Jason Campagna is ―.
What is the average return per transaction made by Jason Campagna?
The average return per transaction made by Jason Campagna is ―.
What stocks does Jason Campagna hold?
Jason Campagna holds: ICPT, QTTB stocks.
What was Jason Campagna’s latest transaction?
Jason Campagna latest transaction was an Uninformative Buy of ―.
What was Jason Campagna's most profitable transaction?
Jason Campagna’s most profitable transaction was an Informative Sell of ICPT stock on August 20, 2020. The return on the trade was 73.30%.
What is Jason Campagna's role in Intercept Pharma?
Jason Campagna's role in Intercept Pharma is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.